Cocrystal Pharma (NASDAQ:COCP) Releases Earnings Results, Misses Estimates By $0.02 EPS

Cocrystal Pharma (NASDAQ:COCP – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.02), FiscalAI reports. The firm had revenue of $0.11 million during the quarter, compared to analyst estimates of $0.10 million.

Cocrystal Pharma Stock Performance

Shares of COCP stock opened at $0.98 on Monday. The stock’s 50 day simple moving average is $1.08 and its 200 day simple moving average is $1.10. The company has a market capitalization of $18.88 million, a price-to-earnings ratio of -1.29 and a beta of 1.60. Cocrystal Pharma has a twelve month low of $0.76 and a twelve month high of $2.03.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Weiss Ratings downgraded shares of Cocrystal Pharma from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, August 21st. HC Wainwright reissued a “buy” rating on shares of Cocrystal Pharma in a report on Friday, October 9th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Get Our Latest Stock Analysis on COCP

Cocrystal Pharma Company Profile

(Get Free Report)

Cocrystal Pharma, Inc. is a biotechnology company focused on discovering and developing antiviral medicines. Its research targets viral proteins involved in replication, with the goal of developing treatments for infections including influenza, hepatitis C, norovirus and coronaviruses. The company uses structure-based drug discovery and computational methods to identify compounds that act on these viral targets. Its investigational programs have included candidates for influenza A and hepatitis C; these are research-stage medicines and are not approved treatments.

Featured Articles

Earnings History for Cocrystal Pharma (NASDAQ:COCP)

Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.